S. Mikkelsen

The hypoalgesic effect of oxycodone in human experimental pain models in relation to the CYP2D6 oxidation polymorphism.

F. Nielsen, K. Brøsen, R. Pedersen, 2009, Basic & clinical pharmacology & toxicology.

Impact of the CYP2D6 genotype on post‐operative intravenous oxycodone analgesia

K. Brøsen, S. Zwisler, S. H. Sindrup, 2010, Acta anaesthesiologica Scandinavica.

Lack of Association of OPRM1 and ABCB1 Single‐Nucleotide Polymorphisms to Oxycodone Response in Postoperative Pain

K. Brøsen, C. Verstuyft, L. Becquemont, 2012, Journal of clinical pharmacology.

Norketamine, the main metabolite of ketamine, is a non-competitive NMDA receptor antagonist in the rat cortex and spinal cord.

F. M. Borgbjerg, B. Ebert, S. Mikkelsen, 1997, European journal of pharmacology.

The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes

K. Brøsen, C. Verstuyft, L. Becquemont, 2009, Fundamental & clinical pharmacology.

The antinociceptive effect and adverse drug reactions of oxycodone in human experimental pain in relation to genetic variations in the OPRM1 and ABCB1 genes

K. Brøsen, C. Verstuyft, L. Becquemont, 2009, Fundamental & Clinical Pharmacology.

Lack of Association of OPRM1 and ABCB1 Single‐Nucleotide Polymorphisms to Oxycodone Response in Postoperative Pain

K. Brøsen, C. Verstuyft, L. Becquemont, 2012, Journal of clinical pharmacology.